Earth-friendly-assessed UV-spectrophotometric approaches for concurrent determination of mirabegron and solifenacin succinate in different matrices

Different approaches for the assessment of greenness of spectrophotometric methodologies utilized for resolving the spectral overlap of newly approved binary hypoglycemic pharmaceutical mixture

(2022) Michael Gamal Fawzy et al.   SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY

Innovative earth-friendly UV-spectrophotometric technique for in-vitro dissolution testing of miconazole nitrate and nystatin in their vaginal suppositories: Greenness assessment

(2022) Ahmed R Mohamed et al.   JOURNAL OF AOAC INTERNATIONAL

Utility of Silver-nanoparticles for Nano-fluorimetric Determination of Vancomycin Hydrochloride in Pharmaceutical Formulation and Biological Fluids: Greenness Assessment

(2022) Ahmed R. Mohamed   JOURNAL OF FLUORESCENCE

Simultaneous analysis of two drugs used as supportive treatment for COVID-19: comparative statistical studies and analytical ecological appraisal

(2022) Hany Ibrahim et al.   BMC Chemistry

Comparative study of novel green UV-spectrophotometric platforms for simultaneous rapid analysis of flumethasone pivalate and clioquinol in their combined formulation

(2021) Rania A. Sayed et al.   DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY

Spectrophotometric Determination of Aspirin and Omeprazole in the presence of Salicylic Acid as a Degradation Product: A Comparative Evaluation of Different Univariate/Multivariate Post Processing Algorithms

(2021) Manal S Elmasry et al.   JOURNAL OF AOAC INTERNATIONAL

Simple mathematical data processing method for the determination of sever overlapped spectra of linagliptin and empagliflozin in their pure forms and pharmaceutical formulation: Fourier self deconvulated method

(2021) Manal S. Elmasry et al.   SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY

Smart UV-spectrophotometric platforms for rapid green analysis of miconazole nitrate and nystatin in their combined suppositories and in vitro dissolution testing

(2021) Rania A. Sayed et al.   DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY

High-Performance Thin-Layer Chromatographic Method for the Estimation of Mirabegron and Solifenacin Succinate Used in the Treatment of Overactive Bladder Syndrome

(2019) Dimal A. Shah et al.   JPC-JOURNAL OF PLANAR CHROMATOGRAPHY-MODERN TLC

Long-term Safety and Efficacy of Mirabegron and Solifenacin in Combination Compared with Monotherapy in Patients with Overactive Bladder: A Randomised, Multicentre Phase 3 Study (SYNERGY II)

(2018) Christian Gratzke et al.   EUROPEAN UROLOGY

Patient-reported outcomes from SYNERGY, a randomized, double-blind, multicenter study evaluating combinations of mirabegron and solifenacin compared with monotherapy and placebo in OAB patients

(2017) Dudley Robinson et al.   NEUROUROLOGY AND URODYNAMICS

Overactive Bladder

(2016) Nicola White et al.   OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA

Pharmacokinetics of Mirabegron, a β3-Adrenoceptor Agonist for Treatment of Overactive Bladder, in Healthy East Asian Subjects

(2015) Hiromi Iitsuka et al.   CLINICAL THERAPEUTICS

Combination Treatment with Mirabegron and Solifenacin in Patients with Overactive Bladder: Efficacy and Safety Results from a Randomised, Double-blind, Dose-ranging, Phase 2 Study (Symphony)

(2015) Paul Abrams et al.   EUROPEAN UROLOGY

Do we need a new definition of the overactive bladder syndrome? ICI-RS 2013

(2014) Marcus J. Drake   NEUROUROLOGY AND URODYNAMICS

Single dose pharmacokinetics and absolute bioavailability of mirabegron, a ?3-adrenoceptor agonist for treatment of overactive bladder

(2012) Charlotte Eltink et al.   INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS

Pathophysiology of overactive bladder

(2012) Mai A. Banakhar et al.   INTERNATIONAL UROGYNECOLOGY JOURNAL